Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
FSTX

Overview Financials Analysis Smart Money

F-star Therapeutics, Inc.

FSTX · NASDAQ

Analyze with AI

Filings1

Total reported value$284.8K

Manager	Shares	Value	Change
S. MUOIO & CO. LLC	40K	$284.8K	+50.0%

SymbolFSTX

Market Cap$156.5M

IPO Date2021-05-07

CEOEliot Richard Forster

Employees84

SectorHealthcare

IndustryBiotechnology

CountryGB

ExchangeNASDAQ Capital Market

Aimei Health Technology Co., Ltd

AFJK

$53.74

+106.62%

Safe and Green Development Corporation

SGD

$0.3013

+70.23%

Athira Pharma, Inc.

ATHA

$6.87

+66.14%

Sable Offshore Corp.

SOC

$8.37

+58.43%

Trump Media & Technology Group Corp.

DJT

$15.12

+44.36%

Peers

Theseus Pharmaceuticals, Inc.

THRX · NASDAQ

$4.07

+0.12%

Selecta Biosciences, Inc.

SELB · NASDAQ

$0.8812

-8.00%

eXoZymes, Inc.

EXOZ · NASDAQ

$11.75

-3.33%

Pardes Biosciences, Inc.

PRDS · NASDAQ

$2.18

+0.93%

aTyr Pharma, Inc.

ATYR · NASDAQ

$0.7087

-0.13%

Vaccitech plc

VACC · NASDAQ

$5.00

+11.36%

NGM Biopharmaceuticals, Inc.

NGM · NASDAQ

$1.54

-1.28%

Sesen Bio, Inc.

SESN · NASDAQ

$0.6288

+7.29%

Paratek Pharmaceuticals, Inc.

PRTK · NASDAQ

$2.23

+1.83%

Decibel Therapeutics, Inc.

DBTX · NASDAQ

$4.91

-0.81%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.